Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities / Heidi Mohamed Abdel-Mageed, Nermeen Zakaria AbuelEzz, Rasha Ali Radwan, Saleh Ahmed Mohamed
Abstract The fast progress in nanomedicine and nanoparticles (NP) materials presents unconventional solutions which are expected to revolutionise health care with great potentials including, enhanced efficacy, bioavailability, drug targeting, and safety. This review provides a comprehensive update on widely used organic and inorganic NP with emphasis on the recent development, challenges and future prospective for bio applications where, further investigations into innovative synthesis methodologies, properties and applications of NP would possibly reveal new improved biomedical relevance. NP exhibits exceptional physical and chemical properties due to their high surface area to volume ratio and nanoscale size, which led to breakthroughs in therapeutic, diagnostic and screening techniques repeated line. Finally, an update of FDA-approved NP is explored where innovative design engineering allowed a paradigmatic shift in their market share. This review would serve as a discerning comprehensive source of information for learners who are seeking a cutting-edge review but have been astounded by the size of publications.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Journal of microencapsulation - 38(2021), 6, Seite 414-436 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abdel-Mageed, Heidi Mohamed [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Themen: |
Biomedical applications |
|---|
| Umfang: |
1 Online-Ressource (23 p) |
|---|
| doi: |
10.1080/02652048.2021.1942275 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
KFL011116323 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL011116323 | ||
| 003 | DE-627 | ||
| 005 | 20231109210011.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230609s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/02652048.2021.1942275 |2 doi | |
| 035 | |a (DE-627)KFL011116323 | ||
| 035 | |a (KFL)prod_LgpH_10.1080/02652048.2021.1942275 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Abdel-Mageed, Heidi Mohamed |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities |c Heidi Mohamed Abdel-Mageed, Nermeen Zakaria AbuelEzz, Rasha Ali Radwan, Saleh Ahmed Mohamed |
| 264 | 1 | |c 2021 | |
| 300 | |a 1 Online-Ressource (23 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The fast progress in nanomedicine and nanoparticles (NP) materials presents unconventional solutions which are expected to revolutionise health care with great potentials including, enhanced efficacy, bioavailability, drug targeting, and safety. This review provides a comprehensive update on widely used organic and inorganic NP with emphasis on the recent development, challenges and future prospective for bio applications where, further investigations into innovative synthesis methodologies, properties and applications of NP would possibly reveal new improved biomedical relevance. NP exhibits exceptional physical and chemical properties due to their high surface area to volume ratio and nanoscale size, which led to breakthroughs in therapeutic, diagnostic and screening techniques repeated line. Finally, an update of FDA-approved NP is explored where innovative design engineering allowed a paradigmatic shift in their market share. This review would serve as a discerning comprehensive source of information for learners who are seeking a cutting-edge review but have been astounded by the size of publications | ||
| 653 | |a Nanomedicine | ||
| 653 | |a nanotechnology | ||
| 653 | |a drug delivery systems | ||
| 653 | |a nanoparticles | ||
| 653 | |a biomedical applications | ||
| 653 | |a FDA | ||
| 653 | |a drug targeting | ||
| 700 | 1 | |a AbuelEzz, Nermeen Zakaria |e verfasserin |4 aut | |
| 700 | 1 | |a Radwan, Rasha Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Mohamed, Saleh Ahmed |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of microencapsulation |d Abingdon : Taylor & Francis Group, 1984 |g 38(2021), 6, Seite 414-436 |h Online-Ressource |w (DE-627)KFL000005967 |w (DE-600)1491079-2 |w (DE-576)079719244 |x 1464-5246 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2021 |g number:6 |g pages:414-436 |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/tandf-ejournals-pharmazie/doi.org/10.1080/02652048.2021.1942275 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-TFE | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 935 | |i IMPORT_0628_prod_LgpH_02 | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2021 |e 6 |h 414-436 | ||